These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 16243492

  • 1. Management of the febrile neutropenic patient.
    Picazo JJ, Association for Health Research and Development (ACINDES).
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [Abstract] [Full Text] [Related]

  • 2. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 3. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I, Sanz MA.
    Enferm Infecc Microbiol Clin; 1999 Dec; 17 Suppl 2():95-102. PubMed ID: 10605194
    [Abstract] [Full Text] [Related]

  • 4. [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment].
    Durnaá B, Dzierzanowska D.
    Wiad Lek; 2006 Dec; 59(7-8):506-11. PubMed ID: 17209349
    [Abstract] [Full Text] [Related]

  • 5. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
    Butt T, Afzal RK, Ahmad RN, Salman M, Mahmood A, Anwar M.
    J Ayub Med Coll Abbottabad; 2004 Dec; 16(1):18-22. PubMed ID: 15125174
    [Abstract] [Full Text] [Related]

  • 6. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
    Rolston KV.
    Clin Infect Dis; 2005 Apr 01; 40 Suppl 4():S246-52. PubMed ID: 15768330
    [Abstract] [Full Text] [Related]

  • 7. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients.
    Bow EJ.
    Curr Opin Infect Dis; 2011 Dec 01; 24(6):545-53. PubMed ID: 22001945
    [Abstract] [Full Text] [Related]

  • 8. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
    Shenep JL.
    NCI Monogr; 1990 Dec 01; (9):117-22. PubMed ID: 2342588
    [Abstract] [Full Text] [Related]

  • 9. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A, Bucaneve G.
    Rev Clin Exp Hematol; 2005 Dec 01; 9(2):E4. PubMed ID: 16864118
    [Abstract] [Full Text] [Related]

  • 10. Bacterial infections in low-risk, febrile neutropenic patients.
    Kamana M, Escalante C, Mullen CA, Frisbee-Hume S, Rolston KV.
    Cancer; 2005 Jul 15; 104(2):422-6. PubMed ID: 15937905
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.
    Sipsas NV, Bodey GP, Kontoyiannis DP.
    Cancer; 2005 Mar 15; 103(6):1103-13. PubMed ID: 15666328
    [Abstract] [Full Text] [Related]

  • 14. Empiric therapy for febrile neutropenia: what are the choices?
    Aoun M.
    Expert Rev Anti Infect Ther; 2007 Jun 15; 5(3):507-15. PubMed ID: 17547514
    [Abstract] [Full Text] [Related]

  • 15. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
    Rolston KV.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S44-8. PubMed ID: 15250020
    [Abstract] [Full Text] [Related]

  • 16. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.
    Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie W, Langeland N.
    Scand J Infect Dis; 2005 Jul 15; 37(6-7):455-64. PubMed ID: 16012006
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.
    Isr Med Assoc J; 2007 Jun 15; 9(6):424-9. PubMed ID: 17642387
    [Abstract] [Full Text] [Related]

  • 19. [Management of 315neutropenic febrile episodes in a cancer center].
    Dutronc H, Billhot M, Dupon M, Eghbali H, Donamaria C, Dauchy FA, Reiffers J.
    Med Mal Infect; 2009 Jun 15; 39(6):388-93. PubMed ID: 19062208
    [Abstract] [Full Text] [Related]

  • 20. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A, Karmakar PS, Pal J, Chakraborty N, Debnath NB, Mukherjee JD.
    J Indian Med Assoc; 2009 Jan 15; 107(1):21-2, 24-5. PubMed ID: 19588683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.